RNA logo

RNA
Avidity Biosciences Inc

1,677
Mkt Cap
$10.88B
Volume
625,162.00
52W High
$72.61
52W Low
$21.51
PE Ratio
-17.31
RNA Fundamentals
Price
$72.18
Prev Close
$72.14
Open
$72.11
50D MA
$67.44
Beta
1.33
Avg. Volume
3.99M
EPS (Annual)
-$2.89
P/B
5.62
Rev/Employee
$27,869.56
Loading...
Loading...
News
all
press releases
Assenagon Asset Management S.A. Has $2 Million Holdings in Avidity Biosciences, Inc. $RNA
Assenagon Asset Management S.A. raised its position in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 157.0% during the 3rd quarter, according to its most recent filing with the Securities...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Lowered to Hold Rating by Evercore ISI
Evercore ISI downgraded shares of Avidity Biosciences from a "strong-buy" rating to a "hold" rating in a research report on Thursday...
MarketBeat·7d ago
News Placeholder
Mirador Capital Partners LP Purchases 22,666 Shares of Avidity Biosciences, Inc. $RNA
Mirador Capital Partners LP grew its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 54.8% in the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·9d ago
News Placeholder
Frazier Life Sciences Management L.P. Has $17.75 Million Stock Holdings in Avidity Biosciences, Inc. $RNA
Frazier Life Sciences Management L.P. boosted its holdings in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 19.0% during the second quarter, according to its most recent 13F...
MarketBeat·12d ago
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Reaches New 52-Week High - What's Next?
Avidity Biosciences (NASDAQ:RNA) Hits New 12-Month High - Here's Why...
MarketBeat·12d ago
News Placeholder
EcoR1 Capital LLC Sells 57,576 Shares of Avidity Biosciences, Inc. $RNA
EcoR1 Capital LLC lowered its holdings in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 10.3% in the second quarter, according to its most recent disclosure with the SEC. The firm...
MarketBeat·13d ago
News Placeholder
Norges Bank Makes New Investment in Avidity Biosciences, Inc. $RNA
Norges Bank purchased a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 995,118...
MarketBeat·18d ago
News Placeholder
Franklin Resources Inc. Sells 29,465 Shares of Avidity Biosciences, Inc. $RNA
Franklin Resources Inc. lowered its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 44.0% in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·19d ago
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Reaches New 52-Week High - Still a Buy?
Avidity Biosciences (NASDAQ:RNA) Sets New 1-Year High - Here's What Happened...
MarketBeat·19d ago
News Placeholder
JPMorgan Chase & Co. Buys 139,473 Shares of Avidity Biosciences, Inc. $RNA
JPMorgan Chase & Co. lifted its stake in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 31.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·20d ago
<
1
2
...
>

Latest RNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.